SNZZF Stock: Senzime AB (publ) Stock Price, Analysis & Insights

Get live SNZZF stock price $0.48, comprehensive Senzime AB (publ) stock analysis, charts, news, and expert forecast. Real-time SNZZF stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.48

0.00%Today

SNZZF • Senzime AB (publ) • Other OTC • Healthcare

Market Cap

75.24M

Volume

25.00K

52W High

0.74

52W Low

0.45

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Based in Uppsala, Sweden, Senzime AB (publ) is a medical technology company founded in 1999, specializing in the development and commercialization of advanced patient monitoring systems. These systems are designed to oversee individuals under anesthe...

Contact Information

Website: https://senzime.com
Address: Ulls vAeg 41
Country: SE

Investment Analysis & Business Insights

Healthcare

Medical - Devices

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: 0.39) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Senzime AB (publ) shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Senzime AB (publ)
⚠Investors should consider how Senzime AB (publ) fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

75.24M

P/E Ratio (TTM)

-5.32

Beta

0.39

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare SNZZF with peer companies:

Kintor Pharmaceutical Limited (KNTPF)

Price: $0.27
Market cap: 125.85M

Lumos Diagnostics Holdings Limited (LDXHF)

Price: $0.08
Market cap: 59.09M

Oneview Healthcare PLC (ONVVF)

Price: $0.16
Market cap: 122.76M

Orexo AB (publ) (ORXOF)

Price: $2.10
Market cap: 73.77M

Paradigm Biopharmaceuticals Limited (PBIGF)

Price: $0.14
Market cap: 60.07M

Pacific Edge Limited (PFGTF)

Price: $0.16
Market cap: 187.52M

Shield Therapeutics plc (SHIEF)

Price: $0.08
Market cap: 85.56M

SomnoMed Limited (SOMNF)

Price: $0.45
Market cap: 98.59M

Optima Medical Innovations Corp. (TOKIF)

Price: $0.01
Market cap: 101.43M

FamiCord AG (VTIAF)

Price: $6.38
Market cap: 111.13M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.